{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T01:28:22Z","timestamp":1768181302523,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Among the gynaecological cancers, epithelial ovarian cancer (EOC) has the highest lethality because of the high incidence of tumour progression and metastasis. Exploration of the detailed mechanisms underlying EOC metastasis and the identification of crucial targets is important to better estimate the prognosis and improve the treatment of this disease. The present study aimed to identify the role of miR-520h in the prognosis of patients with EOC, and the mechanisms of its involvement in EOC progression. We showed that miR-520h was upregulated in 116 patients with EOC, especially in those with advanced-stage disease, and high miR-520h expression predicted poor outcome. Furthermore, ectopic expression of miR-520h enhanced EOC cell proliferation, migration and invasion, and induced epithelial\u2013mesenchymal transition in vitro and in vivo. miR-520h promoted EOC progression by downregulating Smad7, and subsequently activating the TGF-\u03b2 signalling pathway. Most importantly, TGF-\u03b21 stimulation increased miR-520h expression in EOC cells by upregulating its transcription factor c-Myb. In conclusion, we described the role of the TGF-\u03b21\/c-Myb\/miR-520h\/Smad7 axis in EOC metastasis, and highlighted the possible use of miR-520h as a prognostic marker for EOC.<\/jats:p>","DOI":"10.1038\/s41419-018-0946-6","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T19:11:50Z","timestamp":1535569910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The activation of microRNA-520h\u2013associated TGF-\u03b21\/c-Myb\/Smad7 axis promotes epithelial ovarian cancer progression"],"prefix":"10.1038","volume":"9","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangqian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuju","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"946_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2017. CA Cancer J. Clin. 67, 7\u201330 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"946_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","volume":"1","author":"C Fitzmaurice","year":"2015","unstructured":"Fitzmaurice, C. et al. The global burden of cancer 2013. JAMA Oncol. 1, 505\u2013527 (2015).","journal-title":"JAMA Oncol."},{"key":"946_CR3","first-page":"161","volume":"27","author":"RA Soslow","year":"2008","unstructured":"Soslow, R. A. Histologic subtypes of ovarian carcinoma: an overview. Int. J. Gynecol. Pathol. 27, 161\u2013174 (2008).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"946_CR4","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"GC Jayson","year":"2014","unstructured":"Jayson, G. C., Kohn, E. C., Kitchener, H. C. & Ledermann, J. A. Ovarian cancer. Lancet 384, 1376\u20131388 (2014).","journal-title":"Lancet"},{"key":"946_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40291-016-0242-z","volume":"21","author":"P Samuel","year":"2017","unstructured":"Samuel, P. & Carter, D. R. The diagnostic and prognostic potential of microRNAs in epithelial ovarian carcinoma. Mol. Diagn. Ther. 21, 59\u201373 (2017).","journal-title":"Mol. Diagn. Ther."},{"key":"946_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ygyno.2017.01.029","volume":"145","author":"S Wallace","year":"2017","unstructured":"Wallace, S. et al. Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible. Gynecol. Oncol. 145, 21\u201326 (2017).","journal-title":"Gynecol. Oncol."},{"key":"946_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275\u2013292 (2011).","journal-title":"Cell"},{"key":"946_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2016.04.038","volume":"377","author":"Z Luo","year":"2016","unstructured":"Luo, Z. et al. Tumor microenvironment: The culprit for ovarian cancer metastasis? Cancer Lett. 377, 174\u2013182 (2016).","journal-title":"Cancer Lett."},{"key":"946_CR9","doi-asserted-by":"publisher","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","volume":"309","author":"TL Yeung","year":"2015","unstructured":"Yeung, T. L. et al. Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: Cell and molecular processes in cancer metastasis. Am. J. Physiol. Cell. Physiol. 309, C444\u2013C456 (2015).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"946_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.cell.2009.02.005","volume":"136","author":"A Ventura","year":"2009","unstructured":"Ventura, A. & Jacks, T. MicroRNAs and cancer: short RNAs go a long way. Cell 136, 586\u2013591 (2009).","journal-title":"Cell"},{"key":"946_CR11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997\u20131006 (2008).","journal-title":"Cell Res."},{"key":"946_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","volume":"149","author":"MS Ebert","year":"2012","unstructured":"Ebert, M. S. & Sharp, P. A. Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515\u2013524 (2012).","journal-title":"Cell"},{"key":"946_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2014.03.006","volume":"25","author":"N Valeri","year":"2014","unstructured":"Valeri, N. et al. MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell. 25, 469\u2013483 (2014).","journal-title":"Cancer Cell."},{"key":"946_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","volume":"25","author":"W Zhou","year":"2014","unstructured":"Zhou, W. et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 25, 501\u2013515 (2014).","journal-title":"Cancer Cell."},{"key":"946_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccr.2008.02.013","volume":"13","author":"F Petrocca","year":"2008","unstructured":"Petrocca, F. et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 13, 272\u2013286 (2008).","journal-title":"Cancer Cell."},{"key":"946_CR16","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1038\/onc.2015.43","volume":"34","author":"AK Mitra","year":"2015","unstructured":"Mitra, A. K. et al. Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis. Oncogene 34, 5923\u20135932 (2015).","journal-title":"Oncogene"},{"key":"946_CR17","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1158\/0008-5472.CAN-16-1115","volume":"77","author":"MW Chen","year":"2017","unstructured":"Chen, M. W. et al. The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer. Cancer Res. 77, 1955\u20131967 (2017).","journal-title":"Cancer Res."},{"key":"946_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.canlet.2014.05.022","volume":"351","author":"M Koutsaki","year":"2014","unstructured":"Koutsaki, M., Spandidos, D. A. & Zaravinos, A. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics. Cancer Lett. 351, 173\u2013181 (2014).","journal-title":"Cancer Lett."},{"key":"946_CR19","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1158\/0008-5472.CAN-16-0357","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. Gastric cancer cell proliferation and survival is enabled by a cyclophilin B\/STAT3\/miR-520d-5p signaling feedback loop. Cancer Res. 77, 1227\u20131240 (2017).","journal-title":"Cancer Res."},{"key":"946_CR20","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/onc.2015.168","volume":"35","author":"CM Su","year":"2016","unstructured":"Su, C. M. et al. miR-520h is crucial for DAPK2 regulation and breast cancer progression. Oncogene 35, 1134\u20131142 (2016).","journal-title":"Oncogene"},{"key":"946_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/onc.2012.74","volume":"32","author":"YH Yu","year":"2013","unstructured":"Yu, Y. H. et al. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 32, 431\u2013443 (2013).","journal-title":"Oncogene"},{"issue":"Suppl 4","key":"946_CR22","doi-asserted-by":"publisher","first-page":"S687","DOI":"10.1245\/s10434-014-3812-5","volume":"21","author":"YW Chang","year":"2014","unstructured":"Chang, Y. W. et al. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h\/PP2A\/NF-kappaB signaling in cervical cancer. Ann. Surg. Oncol. 21(Suppl 4), S687\u2013S695 (2014).","journal-title":"Ann. Surg. Oncol."},{"key":"946_CR23","doi-asserted-by":"crossref","first-page":"26516","DOI":"10.18632\/oncotarget.8530","volume":"7","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression. Oncotarget 7, 26516\u201326534 (2016).","journal-title":"Oncotarget"},{"key":"946_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massague","year":"2008","unstructured":"Massague, J. TGFbeta in cancer. Cell 134, 215\u2013230 (2008).","journal-title":"Cell"},{"key":"946_CR25","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1126\/science.1071809","volume":"296","author":"L Attisano","year":"2002","unstructured":"Attisano, L. & Wrana, J. L. Signal transduction by the TGF-beta superfamily. Science 296, 1646\u20131647 (2002).","journal-title":"Science"},{"key":"946_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1126\/science.1135961","volume":"315","author":"M Cordenonsi","year":"2007","unstructured":"Cordenonsi, M. et al. Integration of TGF-beta and Ras\/MAPK signaling through p53 phosphorylation. Science 315, 840\u2013843 (2007).","journal-title":"Science"},{"key":"946_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. EMT: 2016. Cell 166, 21\u201345 (2016).","journal-title":"Cell"},{"key":"946_CR28","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/sj.onc.1208927","volume":"24","author":"J Zavadil","year":"2005","unstructured":"Zavadil, J. & Bottinger, E. P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24, 5764\u20135774 (2005).","journal-title":"Oncogene"},{"key":"946_CR29","doi-asserted-by":"publisher","first-page":"re8","DOI":"10.1126\/scisignal.2005189","volume":"7","author":"DM Gonzalez","year":"2014","unstructured":"Gonzalez, D. M. & Medici, D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci. Signal. 7, re8 (2014).","journal-title":"Sci. Signal."},{"key":"946_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3977","volume":"5","author":"A Parikh","year":"2014","unstructured":"Parikh, A. et al. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Nat. Commun. 5, 2977 (2014).","journal-title":"Nat. Commun."},{"key":"946_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0585-z","volume":"16","author":"S Zhao","year":"2017","unstructured":"Zhao, S. et al. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7\/TGFbeta-mediated epithelial to mesenchymal transition. Mol. Cancer 16, 12 (2017).","journal-title":"Mol. Cancer"},{"key":"946_CR32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrc4019","volume":"15","author":"DD Bowtell","year":"2015","unstructured":"Bowtell, D. D. et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat. Rev. Cancer 15, 668\u2013679 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"946_CR33","doi-asserted-by":"publisher","first-page":"18966","DOI":"10.18632\/oncotarget.3943","volume":"6","author":"S Prislei","year":"2015","unstructured":"Prislei, S. et al. Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer. Oncotarget 6, 18966\u201318979 (2015).","journal-title":"Oncotarget"},{"key":"946_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-7-76","volume":"7","author":"M Takai","year":"2014","unstructured":"Takai, M. et al. The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer. J. Ovarian Res. 7, 76 (2014).","journal-title":"J. Ovarian Res."},{"key":"946_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.400","volume":"7","author":"MR Amoroso","year":"2016","unstructured":"Amoroso, M. R. et al. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition. Cell Death Dis. 7, e2522 (2016).","journal-title":"Cell Death Dis."},{"key":"946_CR36","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/all.12871","volume":"71","author":"X Zhang","year":"2016","unstructured":"Zhang, X., Gu, J., Yu, F. S., Zhou, L. & Mi, Q. S. TGF-beta1-induced transcription factor networks in Langerhans cell development and maintenance. Allergy 71, 758\u2013764 (2016).","journal-title":"Allergy"},{"key":"946_CR37","doi-asserted-by":"publisher","first-page":"6268","DOI":"10.1158\/0008-5472.CAN-12-2270","volume":"72","author":"M Romagnoli","year":"2012","unstructured":"Romagnoli, M. et al. Epithelial-to-mesenchymal transition induced by TGF-beta1 is mediated by Blimp-1-dependent repression of BMP-5. Cancer Res. 72, 6268\u20136278 (2012).","journal-title":"Cancer Res."},{"key":"946_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/1541-7786.MCR-07-0208","volume":"6","author":"L Sun","year":"2008","unstructured":"Sun, L. et al. Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol. Cancer Res. 6, 10\u201320 (2008).","journal-title":"Mol. Cancer Res."},{"key":"946_CR39","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0092-8674(00)80303-7","volume":"89","author":"H Hayashi","year":"1997","unstructured":"Hayashi, H. et al. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89, 1165\u20131173 (1997).","journal-title":"Cell"},{"key":"946_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2013.08.039","volume":"342","author":"Y Wu","year":"2014","unstructured":"Wu, Y. et al. Nutlin-3 inhibits epithelial-mesenchymal transition by interfering with canonical transforming growth factor-beta1-Smad-Snail\/Slug axis. Cancer Lett. 342, 82\u201391 (2014).","journal-title":"Cancer Lett."},{"key":"946_CR41","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.4161\/cc.10.23.18346","volume":"10","author":"V Cesi","year":"2011","unstructured":"Cesi, V. et al. TGFbeta-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER\u2009+\u2009breast cancer cells. Cell Cycle 10, 4149\u20134161 (2011).","journal-title":"Cell Cycle"},{"key":"946_CR42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bbrc.2011.02.140","volume":"407","author":"Y Chen","year":"2011","unstructured":"Chen, Y., Liu, J., Xu, H., Luo, Z. & Zhang, C. Overexpression of the c-Myb but not its leukemogenic mutant DNA-binding domain increased adipogenic differentiation in mesenchymal stem cells. Biochem. Biophys. Res. Commun. 407, 202\u2013206 (2011).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0946-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0946-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0946-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:07:09Z","timestamp":1671538029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0946-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["946"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0946-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"2 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"884"}}